| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $16,849,764 | 28 | 82 |
Sells | $7,231,031 | 6 | 18 |
| COLUMN GROUP III GP, LP | 10 percent owner | 9 | $5.98M | 0 | $0 | $5.98M |
| Kutzkey Tim | 9 | $5.98M | 0 | $0 | $5.98M | |
| TCG Crossover GP II, LLC | 10 percent owner | 10 | $4.88M | 1 | $6.91M | $-2.03M |
| Li Yang | Exec. Vice President, Research | 0 | $0 | 2 | $75,008 | $-75,008 |
| Williams Charles O | Chief Operating Officer | 0 | $0 | 2 | $98,974 | $-98,974 |
| Parker Craig C | Chief Executive Officer | 0 | $0 | 1 | $150,798 | $-150,798 |
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular …
Over the last 12 months, insiders at Surrozen, Inc. have bought $16.85M and sold $7.23M worth of Surrozen, Inc. stock.
On average, over the past 5 years, insiders at Surrozen, Inc. have bought $17.63M and sold $3.63M worth of stock each year.
Highest buying activity among insiders over the last 12 months: COLUMN GROUP III GP, LP (10 percent owner) — $5.98M. Kutzkey Tim () — $5.98M. TCG Crossover GP II, LLC (10 percent owner) — $4.88M.
The last purchase of 106,658 shares for transaction amount of $2.63M was made by TCG Crossover GP II, LLC (10 percent owner) on 2026‑03‑24.
| 2026-07-22 | Sale | TCG Crossover GP II, LLC | 10 percent owner | 325,000 4.2524% | $21.25 | $6.91M | +9.48% | |
| 2026-05-04 | Sale | Li Yang | Exec. Vice President, Research | 1,584 0.022% | $33.33 | $52,799 | -25.26% | |
| 2026-05-04 | Sale | Williams Charles O | Chief Operating Officer | 2,036 0.0283% | $33.33 | $67,866 | -25.26% | |
| 2026-05-04 | Sale | Parker Craig C | Chief Executive Officer | 4,524 0.0629% | $33.33 | $150,798 | -25.26% | |
| 2026-03-24 | TCG Crossover GP II, LLC | 10 percent owner | 106,658 1.2291% | $24.69 | $2.63M | -0.32% | ||
| 2026-03-23 | TCG Crossover GP II, LLC | 10 percent owner | 15,223 0.1752% | $24.90 | $379,051 | -1.11% | ||
| 2026-03-16 | TCG Crossover GP II, LLC | 10 percent owner | 1,190 0.0136% | $24.99 | $29,733 | -1.69% | ||
| 2026-03-13 | TCG Crossover GP II, LLC | 10 percent owner | 35,433 0.4079% | $24.88 | $881,463 | -0.52% | ||
| 2026-03-12 | TCG Crossover GP II, LLC | 10 percent owner | 12,374 0.1393% | $24.99 | $309,166 | -3.13% | ||
| 2026-02-12 | TCG Crossover GP II, LLC | 10 percent owner | 1,093 0.0122% | $23.86 | $26,082 | +1.73% | ||
| 2026-02-11 | TCG Crossover GP II, LLC | 10 percent owner | 17,763 0.1986% | $23.57 | $418,763 | +2.60% | ||
| 2026-02-03 | TCG Crossover GP II, LLC | 10 percent owner | 4,355 0.0483% | $21.94 | $95,549 | +8.97% | ||
| 2026-02-02 | TCG Crossover GP II, LLC | 10 percent owner | 731 0.0081% | $21.38 | $15,629 | +13.79% | ||
| 2026-01-30 | TCG Crossover GP II, LLC | 10 percent owner | 4,271 0.0495% | $21.39 | $91,357 | +16.68% | ||
| 2026-01-20 | Kutzkey Tim | 18,052 0.2296% | $19.60 | $353,817 | +39.43% | |||
| 2026-01-20 | COLUMN GROUP III GP, LP | 10 percent owner | 18,052 0.2296% | $19.60 | $353,817 | +39.43% | ||
| 2026-01-16 | Kutzkey Tim | 2,562 0.0299% | $20.00 | $51,240 | +25.30% | |||
| 2026-01-16 | COLUMN GROUP III GP, LP | 10 percent owner | 2,562 0.0299% | $20.00 | $51,240 | +25.30% | ||
| 2026-01-15 | Kutzkey Tim | 11,893 0.138% | $19.89 | $236,540 | +25.25% | |||
| 2026-01-15 | COLUMN GROUP III GP, LP | 10 percent owner | 11,893 0.138% | $19.89 | $236,540 | +25.25% |
| Kutzkey Tim | 1016658 13.5964% | $30.62M | 10 | 0 | <0.0001% | |
| COLUMN GROUP III GP, LP | 10 percent owner | 1016658 13.5964% | $30.62M | 11 | 0 | +3.03% |
| TCG Crossover GP II, LLC | 10 percent owner | 574047 7.6771% | $17.29M | 10 | 1 | |
| Williams Charles O | Chief Operating Officer | 16571 0.2216% | $499,118.52 | 1 | 3 | <0.0001% |
| Parker Craig C | Chief Executive Officer | 16553 0.2214% | $498,576.36 | 1 | 1 | <0.0001% |
| Consonance Capman GP, LLC | director | 500000 6.6868% | $15.06M | 1 | 0 | |
| BLUTT MITCHELL J MD | director | 434000 5.8041% | $13.07M | 2 | 1 | |
| Consonance Life Sciences | director | 434000 5.8041% | $13.07M | 2 | 1 | |
| Livingston Kevin Harold | Chief Financial Officer | 434000 5.8041% | $13.07M | 2 | 1 | |
| Soffer Benny | director | 434000 5.8041% | $13.07M | 2 | 1 |
$22,710,871 | 107 | 8.53% | $220.62M | |
$6,146,922 | 96 | -4.70% | $233.68M | |
$19,239,249 | 50 | -2.24% | $238.33M | |
$168,352,523 | 35 | 13.58% | $218.79M | |
$295,092,700 | 21 | -0.27% | $237.78M |
| Increased Positions | 43 | +153.57% | 4M | +59.95% |
| Decreased Positions | 9 | -32.14% | 1M | -18.48% |
| New Positions | 25 | New | 2M | New |
| Sold Out Positions | 7 | Sold Out | 944,382 | Sold Out |
| Total Postitions | 62 | +121.43% | 9M | +41.47% |
| Column Group Llc | $32,320.00 | 16.66% | 1.5M | 0 | 0% | 2025-09-30 |
| Stempoint Capital Lp | $15,375.00 | 7.93% | 713,463 | +26,924 | +3.92% | 2025-09-30 |
| Vr Adviser, Llc | $13,640.00 | 7.03% | 632,931 | 0 | 0% | 2025-09-30 |
| Ra Capital Management, L.P. | $12,987.00 | 6.7% | 602,626 | 0 | 0% | 2025-09-30 |
| 5Am Venture Management, Llc | $6,681.00 | 3.44% | 310,000 | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $5,741.00 | 2.96% | 266,418 | +47,468 | +21.68% | 2025-09-30 |
| Vivo Capital, Llc | $5,603.00 | 2.89% | 260,000 | 0 | 0% | 2025-09-30 |
| Stonepine Capital Management, Llc | $5,391.00 | 2.78% | 250,146 | -55,883 | -18.26% | 2025-09-30 |
| Samsara Biocapital, Llc | $5,202.00 | 2.68% | 241,400 | 0 | 0% | 2025-09-30 |
| Nantahala Capital Management, Llc | $4,946.00 | 2.55% | 229,527 | 0 | 0% | 2025-09-30 |